Skip to main content
Clinical Trials/NCT04563715
NCT04563715
Enrolling by Invitation
N/A

Regular HIV Testing and HIV Prevention Among At-Risk Latino Men in the Heartland

Medical College of Wisconsin3 sites in 1 country456 target enrollmentNovember 16, 2020
ConditionsHIV Infections

Overview

Phase
N/A
Intervention
Not specified
Conditions
HIV Infections
Sponsor
Medical College of Wisconsin
Enrollment
456
Locations
3
Primary Endpoint
Mean percentage of participants who report having had unprotected sex with a casual partner.
Status
Enrolling by Invitation
Last Updated
4 years ago

Overview

Brief Summary

This study is a randomized controlled trial that evaluates the efficacy of a network intervention to promote regular HIV testing and prevention (risk reduction and PrEP awareness and referrals) among friendship networks of Latino men who have sex with men and transwomen (LMSMT) in three mid sized Midwestern cities.

Detailed Description

To benefit from early HIV diagnosis, the CDC suggests that groups at higher HIV risk get tested regularly. The study will evaluate the efficacy of an intervention to promote regular HIV testing and prevention (risk reduction and PrEP awareness and referrals) among friendship networks of Latino men who have sex with men and transwomen (LMSMT) in three midsized Midwestern cities. The intervention uses the relationships that permeate networks of LMSMT by training well-positioned members to encourage a collective response to the epidemic and to disseminate HIV testing and prevention messages and resources within the network. Thus, we will (a) recruit 36 friendship networks of LMSMT in Milwaukee, Cleveland, and Indianapolis (N ≈ 432); (b) test them for HIV and recommend that they test regularly; (c) invite key members of 18 randomly selected networks to a 4-session training to promote regular HIV testing and prevention in their networks; (d) conduct chart reviews to verify regular testing and PrEP visits and assess regular testing, PrEP visits, and risk behavior and mediators at 6, 12 and 18-month follow up.

Registry
clinicaltrials.gov
Start Date
November 16, 2020
End Date
December 2026
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Laura R. Glasman

Associate professor

Medical College of Wisconsin

Eligibility Criteria

Inclusion Criteria

  • Latinx men who have sex with men or transgender women 18 or more years of age.
  • Lives in the Milwaukee, Cleveland or Indianapolis area.
  • Can provide informed consent.
  • Additional inclusion criteria for networks: 80% or more of the network is of Latinx descent.

Exclusion Criteria

  • Cis-gender female.
  • Did not have sex with men or identify as homosexual or bisexual.
  • Cannot provide consent.

Outcomes

Primary Outcomes

Mean percentage of participants who report having had unprotected sex with a casual partner.

Time Frame: Past 6 months

Participants will complete surveys in which they will report whether they had unprotected sex with a casual partner.

Mean percentage of PrEP-eligible participants who report having consulted with a provider about PrEP.

Time Frame: Past 6 months

Participants will complete surveys in which they will report whether they consulted with a provider about PrEP.

Mean percentage of participants who report having tested for HIV in the past 6 months.

Time Frame: Past 6 months

Participants will complete surveys assessing HIV testing behavior.

Mean percentage of participants who report having tested for HIV twice in the past 12 months.

Time Frame: Past 12 months

Participants will complete surveys assessing HIV testing behavior.

Study Sites (3)

Loading locations...

Similar Trials